Athenex, Inc.
ACETAMIDO-PHENYLBENZAMIDE DERIVATIVES AND METHODS OF USING THE SAME
Last updated:
Abstract:
The present disclosure relates to compounds of Formula (I): ##STR00001## and to their prodrugs, pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for the treatment of disorders in which expression of P-glycoprotein and/or cytochrome P450 (e.g., CYP3A4) is modulated (e.g., cancers which have developed multi-drug resistance).
Status:
Application
Type:
Utility
Filling date:
7 Oct 2021
Issue date:
7 Apr 2022